This statistic represents the medicines in development for cancer in the United States as of year-end 2020. At that moment, most medicines in development concerning cancer were reported for solid tumors with a total of 527 medicines in development.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
PhRMA. (December 14, 2020). Medicines in development for cancer in the United States as of end-2020, by all types [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 26, 2026, from /statistics/248567/medicines-in-development-for-cancer-in-the-us/
PhRMA. "Medicines in development for cancer in the United States as of end-2020, by all types." Chart. December 14, 2020. ÌÇÐÄÆƽâ°æ. Accessed July 26, 2026. /statistics/248567/medicines-in-development-for-cancer-in-the-us/
PhRMA. (2020). Medicines in development for cancer in the United States as of end-2020, by all types. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 26, 2026. /statistics/248567/medicines-in-development-for-cancer-in-the-us/
PhRMA. "Medicines in Development for Cancer in The United States as of End-2020, by All Types." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 14 Dec 2020, /statistics/248567/medicines-in-development-for-cancer-in-the-us/
PhRMA, Medicines in development for cancer in the United States as of end-2020, by all types ÌÇÐÄÆƽâ°æ, /statistics/248567/medicines-in-development-for-cancer-in-the-us/ (last visited July 26, 2026)
Medicines in development for cancer in the United States as of end-2020, by all types [Graph], PhRMA, December 14, 2020. [Online]. Available: /statistics/248567/medicines-in-development-for-cancer-in-the-us/
